Wednesday, February 10, 2010, 2:15PM AEST - The Australian Stockmarket closes in 1 hour and 50 minutes.
To create a watchlist or portfolio of shares, Register

Inovio Biomedical Corporation (INO)

8:00AM AEST: 1.18 USD  Down 0.05 (4.07%)  
 MORE ON INO 
Quotes
Charts
Technical Analysis
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
HeadlinesGet Headlines for:
Mon, Feb 8, 2010
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
Business Wire (Mon, Feb 8)
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
Business Wire (Mon, Feb 8)
Fri, Feb 5, 2010
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
Indie Research (Fri, Feb 5)
Wed, Feb 3, 2010
Inovio Biomedical to Present at BIO CEO & Investor Conference
Business Wire (Wed, Feb 3)
Thu, Jan 28, 2010
Inovio Unveils Skin Electroporation Technology for Delivering DNA Vaccines
Business Wire (Thu, Jan 28)
Wed, Jan 20, 2010
Inovio Biomedical to Present at Partnering and Vaccine Conferences
Business Wire (Wed, Jan 20)
Mon, Jan 11, 2010
Inovio Expands DNA Vaccine Intellectual Property License with University of Pennsylvania
Business Wire (Mon, Jan 11)
Fri, Jan 8, 2010
VGX Animal Health's Growth Hormone Releasing Hormone Shows Advantages Compared to Current Growth Hormone Therapies Used in Pigs
Business Wire (Fri, Jan 8)
Thu, Jan 7, 2010
Inovio Biomedical to Present at OneMedForum Investor Conference
Business Wire (Thu, Jan 7)
Wed, Jan 6, 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Business Wire (Wed, Jan 6)
Wed, Dec 30, 2009
Swine Flu Vaccine News Back From the Dead
Indie Research (Wed, Dec 30)
Thu, Dec 24, 2009
Mentor Capital Cancer Vaccine Investing Update
at Seeking Alpha (Thu, Dec 24)
Mon, Dec 21, 2009
Inovio Biomedical Appoints Electroporation Delivery Expert Dr. Iacob Mathiesen to Its Scientific Advisory Board
Business Wire (Mon, Dec 21)
Tue, Dec 1, 2009
Inovio Biomedical’s hepatitis C vaccine progresses
at bizjournals.com (Tue, Dec 1)
Inovio Partner Announces Completion of Phase I DNA Vaccine Study
Business Wire (Tue, Dec 1)
Sat, Nov 21, 2009
Biotech Stocks: Inovio, Merck gain; Novavax falls
at MarketWatch (Sat, Nov 21)
DryShips, Synovus: Late Volume Plays
at TheStreet.com (Sat, Nov 21)
NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Business Wire (Sat, Nov 21)
Biotech Stocks: Inovio soars, Novavax falls in early action
at MarketWatch (Sat, Nov 21)
Fri, Nov 20, 2009
Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
Business Wire (Fri, Nov 20)
INOVIO BIOMEDICAL CORP Files SEC form 8-K/A, Change in Directors or Principal Officers
EDGAR Online (Fri, Nov 20)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News7 Indices